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tion of between 4 and 13 million people (Fig 1) depend-
ing on the local transplant activity. It has both first
refusal of organs in the zone and an obligation to
retrieve organs that cannot be used locally. The primary
aim of this system is to avoid coupled retrieval to allo-
cation, minimize delay in donor procedures, and dimin-
ish unnecessary movement of retrieval teams.
During the past 5 years we have used donor hearts
and lungs retrieved by other teams when the distant car-
diothoracic surgeon was comfortable in performing
retrieval for us. This study aimed to investigate whether
the use of donor thoracic organs retrieved by other
teams under the regulation of the zonal allocation
scheme affected the outcome of thoracic organ trans-
plantation in our center.
Patients and methods
We analyzed the results of 451 consecutive thoracic organ
transplantation procedures (280 orthotopic hearts, 73 single
lungs, 32 double lungs, and 34 heart-lung blocks) performed
at Wythenshawe Hospital, Manchester, United Kingdom,
between April 1987 and November 1998. Organs were divid-
I n recent years thoracic organ transplantation hasbecome an effective therapy for patients with end-
stage cardiorespiratory disease. As an increasing num-
ber of centers have participated in thoracic organ trans-
plantation, more thoracic surgeons have learned the
techniques of procurement and implantation for heart,
lung, and heart-lung transplantation. Before November
1993 in the United Kingdom, each of the 8 thoracic
transplant centers sent their own teams to the donor
hospital for retrieval. Zonal organ allocation for tho-
racic organ procurement has since been introduced.1
Each center has a geographic zone containing a popula-
Objectives: The purpose of this study was to analyze the impact of the
zonal allocation system for thoracic organs on the outcome of our trans-
plant activity. Methods: We analyzed the results of thoracic transplants
performed between 1987 and 1998. The transplants were divided into 3
groups: local donors retrieved by our team (171 hearts and 61 lungs; DL
group); distant donors retrieved by our team (58 hearts and 35 lungs;
DD group); and distant donors retrieved by other teams (51 hearts and
41 lungs; DX group). Results: No significant differences were observed
among the groups in early postoperative events for either heart or lung
transplantation. Heart transplants: Cardiac index was 2.6 ± 0.4 L/m2 for
the DL group, 2.7 ± 0.6 L/m2 for the DD group, and 2.5 ± 0.7 L/m2 for
the DX group (P = .4). The 30-day mortalities were 9.1%, 9.1%, and
8.3% (P = .5) and the 1-year survivals 83%, 80%, and 82% (P = .4) for
the DL, DD, and DX groups, respectively. Lung transplants: Alveolar-
arterial oxygen gradient was 358 ± 19 mm Hg for the DL group, 345 ±
17 mm Hg for the DD group, and 329 ± 21 mm Hg for the DX group (P
= .07). The 30-day mortalities were 9.9%, 10.5%, and 12.8% (P = .2) and
the 1-year survivals 79%, 75%, and 77% (P = .3) for the DL, DD, and
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ed into 3 groups: (1) organs from local donors retrieved by
our team (171 hearts, 61 lungs, and 19 heart-lung blocks—
DL group); (2) organs from distant donors retrieved by our
team (58 hearts, 35 lungs, and 14 heart-lung blocks—DD
group); and (3) organs from distant donors retrieved by
another team (51 hearts, 41 lungs, and 1 heart-lung block—
DX group).
Heart re-transplantation and heterotopic heart transplant
recipients were excluded from the study. Follow-up was com-
plete to December 1998 or to the time of recipient death.
Mean follow-up was 77 ± 35 months for heart transplant
recipients and 39 ± 12 months for lung recipients.
Donor selection. As in other United Kingdom transplant
centers, donor selection criteria at our center have been liber-
alized to attract a larger donor pool. It has already been
demonstrated that marginal heart and lung donors can be opti-
mized with careful intensive care management and success-
fully used for selected recipients.2 The criteria for selection of
heart and lung donors are widely established3,4 and approved
by the United Kingdom Transplant Support Service Authority
(UKTSSA). They are summarized in Tables I and II. All heart
donors were assessed according to clinical history, electro-
cardiographic changes, inotropic support, and arterial blood
pressure measurement in addition to the operative evaluation.
Intracardiac pressures were measured in 58% of the accepted
donor hearts. Lung donors were assessed on the basis of clin-
ical history, radiologic appearances, and duration of mechan-
ical ventilation and arterial oxygen tension. Donor arterial
oxygen tension was determined during mechanical ventila-
tion at an inspired oxygen tension of 1.0 and a positive end-
expiratory pressure of 5 cm H2O. Donors with a history of
asthma or those with a smoking history of more than 20 cig-
arettes per day for more than 10 years were not considered for
retrieval. Selective pulmonary vein gases were measured in
45% and 70% of accepted single and double lungs, respec-
tively. Fiberoptic bronchoscopy was used to assess the
bronchial tree in marginal donors. All donor hearts were pre-
served with the standard (1-2 L) St Thomas’ Hospital cardio-
plegic solution. All DL and DD lung donor organs were pre-
served with Euro-Collins solution (60 mL/kg). DX lungs
were also preserved with Euro-Collins solution except in 3
cases of donor core cooling and in 6 procedures in which
Papworth solution was used.
Experienced higher surgical trainee grade surgeons per-
formed both heart and lung procurement for both DL and DD
groups. In the DX group the organs were procured by experi-
enced trainee surgeons in 85% of cases and by a consultant
grade surgeon in 15%.
Assessment of recipient outcome 
Heart transplant recipients. The standard technique for
orthotopic heart transplantation5 was used in 179 cases and
the bicaval Wythenshawe technique6 in 101 cases. Heart
transplant recipients were assessed by measurement of car-
diac index at different intervals after the operation, require-
ment for major inotropic support, clinical features of right-
sided heart failure, echocardiographic evaluation of left
ventricular function, and by analysis of actuarial survival.
Lung transplant recipients. Standard previously described
techniques7,8 were used for single, double, and heart-lung
transplantation. Variables used to evaluate early outcome
included alveolar-arterial oxygen gradient immediately after
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Fig 1. The zonal division of the United Kingdom to 8 loca-
tions. Wythenshawe hospital is area 5.
Table I. Heart, heart-lung, and lung donor criteria
Criteria Organ
Meet criteria for brain death Heart, lung, heart-lung
Donor consent obtained Heart, lung, heart-lung
Age up to 60 years Heart, lung, heart-lung
Size: recipient ± 20% body weight of Heart, heart-lung
donor
ABO blood group compatibility Heart, lung, heart-lung
No active infection Heart, lung, heart-lung
No extracerebral malignant disease Heart, lung, heart-lung
Normal heart, no history of pre-existing Heart, heart-lung
heart disease
Inotropic support < 10 µg · kg–1 · min–1 Heart, heart-lung
of dopamine
No cardiac trauma Heart, heart-lung
Anticipated ischemic time < 4 hours Heart, heart-lung
Satisfactory chest x–ray film Lung, heart-lung
No active chest infection Heart, lung, heart-lung
No chest trauma Heart, lung, heart-lung
No history of asthma or chronic chest Lung, heart-lung
condition
Satisfactory arterial oxygenation Lung, heart-lung
Satisfactory operative assessment Heart, lung, heart-lung
transplantation on return to the intensive therapy unit (ITU)
and at up to 72 hours after the operation, duration of mechan-
ical ventilation, length of ITU stay, length of hospital stay,
and 30-day mortality. Actuarial survival was evaluated.
Statistical analysis. Results are expressed as mean ± stan-
dard deviation. Statistical analysis of results between differ-
ent groups was performed by analysis of variance, c 2, or
Scheffé F test. Actuarial survival was evaluated by the
Kaplan-Meier method.
Results
Donor suitability
Heart transplantation. Age, mean arterial blood pres-
sure, degree of inotropic support, and central venous
pressure were equivalent in the 3 groups (P = .6, .1, .3,
and .2, respectively, Table II). Operative assessment of
heart donors was satisfactory in the 3 groups.
Lung transplantation. No significant difference
among the 3 groups was observed in terms of age, arte-
rial oxygen tension, and duration of mechanical venti-
lation (P = .3, .07, and .3 respectively, Table II).
Operative assessment of lung donors was satisfactory
in the 3 groups.
Recipient profile. No significant difference in age,
sex, and recipient diagnosis was observed among the 3
groups in heart or lung transplantation (Table III).
Early recipient outcome 
Heart transplantation. No difference was observed in
the need for early mechanical support (P = .6) or duration
of mechanical (P = .09) or ventilatory (P = .08) support
among the 3 groups. The DL group had shorter ischemic
times (Table IV), a lower requirement for mechanical
ventilation, and a shorter ITU stay than the DD and DX
groups (Table V). However, these differences did not
achieve statistical significance (P = .07 for ischemic time,
.08 for ventilation time, and .4 for ITU stay).
Lung transplantation. The 3 groups were similar
with regard to arterial oxygen saturation (P = .07),
duration of mechanical ventilation (P = .09), ITU stay
(P = .2), and total hospital stay (P = .3). The DL group
had a lower requirement for mechanical ventilation and
a shorter ITU stay than did the DD and DX groups
(Table VI). However, these differences did not achieve
significance values (P = .07 for ischemic time, .09 for
ventilation time, and .2 for ITU stay, respectively)
(Tables IV and VI).
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Table II. Donor suitability in hearts and lungs in the 3 groups
Variable DL group DD group DX group P value
Heart n = 171 n = 58 n = 51 
1. Age (y) 31 ± 7.3 30 ± 8.6 30 ± 9.4 .6
2. Mean BP (mm Hg) 72 ± 12 67 ± 13 70 ± 10 .1
3. Dopamine (m g · kg–1 · min–1) 6.5 ± 0.9 7.2 ± 0.8 7.4 ± 0.3 .3
4. CVP 7.4 ± 1.2 8.2 ± 0.8 9.1 ± 4 .2
Lungs n = 61 n = 35 n = 41 
1. Age 34 ± 11 35 ± 9 36 ± 10 .3
2. PaO2 (100% O2 PEEP 5 mm3) 346 ± 24 339 ± 27 351 ± 19 .07
3. Mechanical ventilation (h) 53 ± 15 49 ± 14 53 ± 12 .3
DL group, Local donors retrieved by our surgical team; DD group, distant donors retrieved by our surgical team; DX group, distant donors retrieved by another sur-
gical team; BP, blood pressure; CVP, central venous pressure; PEEP, positive end-expiratory pressure.
Table III. Summary of recipient’s profile for heart and lung transplantation
Variable DL group DD group DX group P value
Hearts n = 171 n = 58 n = 51
Ischemic heart disease 82 (47%) 31 (53%) 22 (43%) .6
Cardiomyopathy 79 (48%) 25 (43%) 27 (52%) .5
Others 10 (5%) 2 (4%) 2 (5%) .8
Lungs n = 61 n = 35 n = 41
CF 11 (36%) 6 (34%) 6 (29%) .8
EMP 21 (39%) 13 (37%) 14 (41%) .5
IPF 12 (20%) 8 (23%) 10 (25%) .8
Others 3 (5%) 2 (6%) 2 (5%) .9
Tx type (SLT/DLT) 14/61 6/35 9/41
DL group, Local donors retrieved by our surgical team; DD group, distant donors retrieved by our surgical team; DX group, distant donors retrieved by another surgical
team; CF, cystic fibrosis; EMP, emphysema; IPF, idiopathic pulmonary fibrosis; Tx, transplantation; SLT, single lung transplantation; DLT, double lung transplantation. 
Survival
Heart transplantation. Thirty-day mortality was not
significantly different among the 3 groups (9.1%, 9.1%,
and 8.3% for the DL, DD, and DD groups, respective-
ly; P = .5, Table V). Actuarial 1- and 3-year survivals,
respectively, were 83% and 78% for the DL group,
80% and 75% for the DD group, and 82% and 76% for
the DX group (P = .4 for 1-year survival and P = .5 for
3-year survival, Fig 2).
Lung transplantation. Thirty-day mortality was not
significantly different among the 3 groups (9.9%,
10.5%, and 12.8% for the DL, DD, and DX groups,
respectively, P = .2, Table VI). Actuarial 1-year and 3-
year survivals were 79% and 64%, respectively, for the
DL group, 75% and 63%, respectively, for the DD
group, and 77% and 60%, respectively, for the DX
group (P = .3 for 1-year survival and P = .4 for 3-year
survival, Fig 3).
Changes in hospital visits and traveling distance.
The average number of donor hospitals visited by our
transplant team decreased from 46 hospitals in 1992 to
16 hospitals in 1996. The distance traveled by our
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Table IV. Comparison of ischemic time and use of CPB during lung implantation
Variable DL group DD group DX group P value
Heart n = 171 n = 58 n = 51
Ischemic time (min) 155 ± 26 167 ± 18 170 ± 19 .07
Lungs n = 61 n = 35 n = 41
Ischemic time (min)
SLT 208 ± 47 200 ± 25 216 ± 26 .09
DLT 378 ± 18 368 ± 31 391 ± 9 .07
Use of CBP in lung transplantation (%) 25.6 22.3 20.9 .2
Ischemic time for the DLT group is the ischemic time for the second lung. DL group, Local donors retrieved by our surgical team; DD group, distant donors retrieved
by our surgical team; DX group, distant donors retrieved by another surgical team; SLT, single lung transplantation; DLT, double lung transplantation.
Table V. Result of early recipient outcome of heart transplantation in 3 groups
Variable DL group (n = 171) DD group (n = 58) DX group (n = 51) P value
Cardiac index (L/m2) 2.6 ± 0.4 2.7 ± 0.6 2.5 ± 0.7 .4
EF% > 55% 86% (154/171) 82% (50/58) 88% (44/51) .4
Mechanical support (IABP) 10.5% (18/171) 11% (7/58) 10% (5/51) .6
Right-sided heart failure 23% (41/171) 25% (14/58) 26% (13/51) .5
Days on ventilator 2.1 ± 0.9 2.4 ± 0.8 2.7 ± 1.1 .08
Days in ITU 4.5 ± 0.9 4.8 ± 1.6 4.9 ± 1.1 .4
Length of hospital stay (d) 22 ± 4.4 26 ± 3.6 25 ± 3.4 .3
Death < 30 days 9.1% (15/171) 9.1% (5/58) 8.3% (4/51) .5
DL group, Local donors retrieved by our surgical team; DD group, distant donors retrieved by our surgical team; DX group, distant donors retrieved by another sur-
gical team; EF, ejection fraction; IABP, intra-aortic balloon pumping; ITU, intensive therapy unit.
Table VI. Results of early recipient outcome of lung transplantation in 3 groups
Variable DL group (n = 61) DD group (n = 35) DX group (n = 41) P value
Satisfactory oxygenation
Immediate 358 ± 19 345 ± 17 329 ± 21 .07
24 hours 123 ± 11 130 ± 17 127 ± 9 .5
3 days 116 ± 19 135 ± 9 109 ± 17 .08
Satisfactory x-ray appearance 83% (50/61) 82% (29/35) 79% (32/41) .3
Days on ventilator 6.8 ± 2.9 7.8 ± 3.1 8.1 ± 0.5 .09
Days in ITU 9.9 ± 3.5 9.1 ± 5.2 10.7 ± 4.3 .2
Length of hospital stay (days) 31 ± 3.3 33 ± 2.8 33 ± 2.9 .3
Death < 30 days 9.9% (6/16) 10.5% (4/35) 12.8% (5/41) .2
DL group, Local donors retrieved by our surgical team; DD group, distant donors retrieved by our surgical team; DX group, distant donors retrieved by another sur-
gical team; ITU, intensive therapy unit.
transplant team decreased from an average of 183 miles
per retrieval in 1992 to 76 miles per retrieval in 1996.
Heart-lung transplantation. The number of heart-lung
transplantation procedures has declined in our center
since we successfully introduced our double lung trans-
plantation program. This correlated with the national
decline in the performance of heart-lung transplanta-
tion from 94 transplants in 1994 to 44 operations in 1997.9
We do not think that the zonal allocation would have a
direct impact on the heart-lung transplantation activity.
Discussion
As the techniques of heart and lung preservation have
improved, distant thoracic organ retrieval has become
standard.10-12 Previously each transplant center sent its
own team to the donor hospital for retrieval. Since the
introduction of zonal organization to the United
Kingdom in November 1993, this has been unneces-
sary, because the zonal team is usually present and
capable of harvesting the donor organs. The UKTSSA
initial data highlighted the significance of the zonal
allocation of thoracic organs in the United Kingdom.
Within the zonal allocation scheme, more than 23% of
hearts and 55% of lungs offered for donation were
retrieved by a transplant team from a center not respon-
sible for the subsequent transplant procedure.13 The
exchange rate of thoracic organs between the United
Kingdom transplant centers has increased by 4- or 5-
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Fig 2. Survival figures for the heart transplant recipients. CI, Confidence interval of survival; Pts, number of
patients traced in each group; DL group, local donors retrieved by our surgical team; DD group, distant donor
retrieved by our surgical team; DX group, distant donors retrieved by another surgical team.
fold since its introduction. The scheme has allowed
donor hospitals to be visited by the same transplant
team and has improved efficiency because of less dupli-
cation of surgical staff. It has also offered significant
reduction in the traveling of transplant surgeons
between different zones.
At our institution DL and DD groups started after
commencement of our heart transplantation program in
1987. A small number of DX donor operations (15% of
the total DX organs) also occurred before the introduc-
tion of zonal allocation. After 1993, our activity has
been distributed between the DL and DX groups in
addition to an ongoing DD group, which comprises
lung donors continuously offered to us from surround-
ing European countries. In these cases we have to send
our own team to perform the retrieval operation.
Potentially, our results could have been confounded
by the improvement in outcome of transplantation that
occurred during the period of the study. However,
analysis of our data failed to demonstrate a significant
impact of era on our results. More than 80% of our lung
transplantation activity was performed after 1993, and
all lung transplants performed before the zonal alloca-
tion belonged to only 1 group (DL). For heart trans-
plantation, we did not find a significant difference in
operative or first-year survival between recipients treat-
ed before or after 1993 (operative mortality and first-
year survival were, respectively, 11% and 79% for
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Fig 3. Survival figures for the lung transplant recipients. CI, Confidence interval of survival; Pts, number of
patients traced in each group; DL group, local donors retrieved by our surgical team; DD group, distant donor
retrieved by our surgical team; DX group, distant donors retrieved by another surgical team.
heart transplant recipients treated before 1993 com-
pared with an operative mortality of 8% and a first-year
survival of 87% for recipients treated after 1993 (P = .6
and .1, respectively). A similar outcome between both
eras in our study is supported by data published by the
International Society of Heart and Lung Transplanta-
tion in their annual report.14
In our series the ischemic time of the DD and DX
groups was not significantly longer than that of the DL
group. This could be explained by the early timing of
the recipient operation when distant donor organs were
used. Other factors include the transfer by air of organs
in more than 90% of DD and DX donor operations, the
central location of our center within the United
Kingdom, and the relatively short distance (3 miles)
between our hospital and the local airport.
A major concern at the institution of the new zonal
organ allocation in the United Kingdom was the poten-
tial implications for the outcome of thoracic organ
transplantation at each center. This study has demon-
strated that there has been no significant change in out-
come since November 1993 and that the team has not
affected the outcome used for retrieval. We did not
detect a difference in early outcome using distant donor
organs retrieved by our team and those using donor
organs retrieved by other teams. Although transplanta-
tion using local lung donors tended to have a better
early outcome than those using distant donors, these
differences did not achieve statistical significance. No
difference in 30-day mortality and actuarial survival
was observed among the 3 groups.
The impact of this zonal organ allocation on the num-
ber of heart and lungs transplants is still unclear.
Certainly the number of transplants performed in our
center correlates with the number of revivals performed
in our zone. Initially, we noted an increase in the num-
ber of retrievals performed in our zonal area (from 63
organs in 1993 to 80 organs in 1995), and this was
associated with an increased number of thoracic organ
transplants performed in our center. However, the num-
ber of thoracic organ retrievals and subsequently the
activity of transplants performed have declined to a
number comparable with that observed before zonal
allocation.
In conclusion, the application of zonal organ alloca-
tion for thoracic organs in the United Kingdom has
been safe and successfully applied to our transplanta-
tion program. We have used donor organs retrieved by
other teams and achieved satisfactory outcomes for
both heart and lung transplantation.
We acknowledge Dr Alison Wynn Hann from the
University Department of Statistics at Withington Hospital
for her assistance during preparation and revision of this
manuscript.
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